Deuterium in Drug Discovery and Development

Annual Reports in Medicinal Chemistry

Volumn 46, Issue , 2011, Pages 403-417

  Harbeson, Scott L ^a   Tung, Roger D ^a  

^a Drug Metabolism and Pharmacokinetics   (United States)

Author keywords

Cytochrome P450; Isotope effect; Mechanism based inactivator; Pharmacokinetics; Protease inhibitor

Indexed keywords

EID: 80054107932     PISSN: 00657743     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-386009-5.00003-5     Document Type: Chapter

References (61)

1. Schoenheimer R., Rittenberg D. Physiol. Rev. 1940, 20:218.
2. Baillie T.A. Pharmacol. Rev. 1981, 33:81.
3. Blake M.I., Crespi H.L., Katz J.J. J. Pharm. Sci. 1975, 64:367.
4. Foster A.B. Adv. Drug Res. 1985, 14:1.
5. Kahan F.M. Chem. Eng. News 2009, 87:4.
6. Kushner D.J., Baker A., Dunstall T.G. Can. J. Physiol. Pharmacol. 1999, 77:79.
7. Tung R. Innov. Pharm. Technol. 2010, 32:24.
8. Shao L., Hewitt M.C. Drug News Perspect. 2010, 23:398.
9. Urey H.C., Brickwedde F.G., Murphy G.M. Phys. Rev. 1932, 39:164.
10. Marter W.L., Hayes D.W., Jones D.W. in Encyclopedia of Chemical Processing and Design, Issue 15 1982, 308. Marcel Dekker, Inc., New York, NY. J.C. McKetta, W.A. Cunningham (Eds.).
11. Wiberg K.B. Chem. Rev. 1955, 55:713.
12. Nelson S.D., Trager W.F. Drug Metab. Dispos. 2003, 31:1481.
13. Fisher M.B., Henne K.R., Boer J. Curr. Opin. Drug Discov. Dev. 2006, 9:101.
14. Jenks W.P. Catalysis in Chemistry and Enzymology 1987, Dover Publications Inc., Mineola, NY, p. 243.
15. Ling K.J., Hanzlik R.P. Biochem. Biophys. Res. Commun. 1989, 169:844.
16. Meunier B., de Visser S.P., Shaik S. Chem. Rev. 2004, 104:3947.
17. Pryd D.C., Dalvie D., Hu Q., Jones P., Obach R.S., Tran T.-D. J. Med. Chem. 2010, 53:8441.
18. Northrop D.B. Biochemistry 1975, 14:2644.
19. Horning M.G., Haegele K.D., Sommer K.R., Nowlin J., Stafford M., Thenot J.P. 1976.
20. Guroff G., Daly J.W., Jerina D.M., Renson J., Witkop B., Udenfriend S. Science 1967, 157:1524.
21. Esaki H., Ito N., Sakai S., Maegawa T., Monguchi Y., Sajiki H. Tetrahedron 2006, 62:10954.
22. Esaki H., Aoki F., Umemura M., Kato M., Maegawa T., Monguchi Y., Sajiki H. Chem. Eur. J. 2007, 13:4052.
23. Leis H.J., Fauler G., Windischhofer W. Curr. Org. Chem. 1998, 2:131.
24. Atkinson J.G., Luke M.O. US Patent 3,966,781 1976.
25. Di Costanzo L., Moulin M., Haertlein M., Meilleur F., Christianson D.W. Arch. Biochem. Biophys. 2007, 465:82.
26. Tayar N.E., Waterbeemd H.v.d, Gryllaki M., Testa B., Trager W.F. Int. J. Pharm. 1984, 19:271.
27. Turowski M., Yamakawa N., Meller J., Kimata K., Ikegami T., Hosoya K., Tanaka N., Thornton E.R. J. Am. Chem. Soc. 2003, 125:13836.
28. Perrin C.L., Dong Y. J. Am. Chem. Soc. 2007, 129:4490.
29. Perrin C.L., Ohta B.K., Liberman J., Erdelyi M. J. Am. Chem. Soc. 2005, 127:9641.
30. Schneider F., Mattern-Dogru E., Hillgenberg M., Alken R.-G. Arzneim. Forsch./Drug Res. 2007, 57:293.
31. Flaumenhaft E., Bose S., Crespi H.L., Katz J.J. Int. Rev. Cytol. 1965, 18:313.
32. Jones P.J.H., Leatherdale S.T. Clin. Sci. 1991, 80:277.
33. Blagojevic N., Storr G., Allen J.B., Hatanaka H., Nakagawa H. in Dosimetry & Treatment Planning for Neutron Capture Therapy 1994, 125. Advanced Medical Publishing, Madison, WI. R. Zamenhof, G. Solares, O. Harling (Eds.).
34. Schloerb P.R., Friis-Hansen B.J., Edelman I.S., Solomon A.K., Moore F.D. J. Clin. Invest. 1950, 29:1296.
35. Mutlib A.E., Gerson R.J., Meunier P.C., Haley P.J., Chen H., Gan L.S., Davies M.H., Gemzik B., Christ D.D., Krahn D.F., Markwalder J.A., Seitz S.P., Robertson R.T., Miwa G.T. Toxicol. Appl. Pharmacol. 2000, 169:102.
36. Ruszczycky M.W., Anderson V.E. J. Theor. Biol. 2006, 243:328.
37. Lewis B.E., Schramm V.L. in Isotope Effects in Chemistry and Biology 2006, 1019. CRC Taylor & Francis, Boca Raton, FL. A. Kohen, H.-H. Limbach (Eds.).
38. Schramm V.L. Curr. Opin. Chem. Biol. 2007, 11:529.
39. Shao L., Abolin C., Hewitt C.M.C., Koch P., Varney M. Bioorg. Med. Chem. Lett. 2006, 16:691.
40. Schneider F., Hillgenberg M., Koytchev R., Alken R.-G. Arzneim. Forsch/Drug Res. 2006, 56:295.
41. Maltais F., Jung Y.C., Chen M., Tanoury J., Perni R.B., Mani M., Laitinen L., Huang H., Liao S., Gao H., Tsao H., Block E., Ma C., Shawgo R.S., Town C., Brummel C.L., Howe D., Pazhanisamy S., Raybuck S., Namchuk M., Bennani Y.L. J. Med. Chem. 2009, 52:7993.
42. Chen J., Mannargudi B.M., Xu L., Uetrecht J. Chem. Res. Toxicol. 2008, 21:1862.
43. Tung R., Harbeson S. Patent Application US 2008/0139563-A1 2008.
44. Morales A., Wells D., Tung R., Zelle R., Cheng C., Harbeson S. 2008.
45. Rosenberg R., Roth T., Scharf M., Lankford D.A., Farber R. J. Clin. Sleep Med. 2007, 3:374.
46. Morales A.J., Gallegos R., Uttamsingh V., Cheng C., Harbeson S., Zelle R., Tung R., Wells D. 2008.
47. Wise R., Andrews J.M. Antimicrob. Agents Chemother. 1984, 25:612.
48. Darland G.K., Hajdu R., Kropp H., Kahan F.M., Walker R.W., Vandenheuvel W.J. Drug Metab. Dispos. 1986, 14:668.
49. projects/bdd_10103. http://www.birdspharma.com/.
50. Dalmadi B., Leibinger J., Szeberenyi S., Borbas T., Farkas S., Szombathelyi Z., Tihanyi K. Drug Metab. Dispos. 2003, 31:631.
51. Alken R.-G. Patent Application US 2004/0186136-A1 2004.
52. Yarnell A. Chem. Eng. News 2009, 87:36.
53. Uttamsingh V., Wells D., Soergel D., Zelle R. 2009.
54. Wells D.S., Gallegos R., Uttamsingh V., Cheng C., Bridson G., Masse C., Harbeson S.L., Graham P.B., Zelle R., Tung R., Morales A.J. 2008.
55. Wells D., Soergel D., Zelle R. 2009.
56. Tung R. US Patent 7,687,914 2010.
57. Gallegos R., Uttamsingh V., Morales A., Cheng C., Bridson G., Liu J.F., Tung R., Zelle R., Harbeson S., Wells D.S. 2009.
58. Murray M. Curr. Drug Metab. 2000, 1:67.
59. Liston H.L., DeVane C.L., Boulton D.W., Risch S.C., Markowitz J.S., Goldman J. J. Clin. Psychopharmacol. 2002, 22:169.
60. Alfaro C.L., Lam Y.M., Simpson J., Ereshefsky L. J. Clin. Pharmacol. 2000, 40:58.
61. Harbeson S.L., Tung R.D. Patent Application US 2009/0036357-A1 2009.